These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16620789

  • 21. In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation.
    Shibamoto Y, Tachi Y, Tanabe K, Hatta H, Nishimoto S.
    Int J Radiat Oncol Biol Phys; 2004 Feb 01; 58(2):397-402. PubMed ID: 14751508
    [Abstract] [Full Text] [Related]

  • 22. Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex.
    Yamamoto N, Renfrew AK, Kim BJ, Bryce NS, Hambley TW.
    J Med Chem; 2012 Dec 27; 55(24):11013-21. PubMed ID: 23199008
    [Abstract] [Full Text] [Related]

  • 23. A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs.
    Bustamante FL, Miranda FS, Castro FA, Resende JA, Pereira MD, Lanznaster M.
    J Inorg Biochem; 2014 Mar 27; 132():37-44. PubMed ID: 24326134
    [Abstract] [Full Text] [Related]

  • 24. N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization.
    Sykes BM, Atwell GJ, Hogg A, Wilson WR, O'Connor CJ, Denny WA.
    J Med Chem; 1999 Feb 11; 42(3):346-55. PubMed ID: 9986704
    [Abstract] [Full Text] [Related]

  • 25. The effect of sulfonate leaving groups on the hypoxia-selective toxicity of nitro analogs of the duocarmycins.
    Ashoorzadeh A, Atwell GJ, Pruijn FB, Wilson WR, Tercel M, Denny WA, Stevenson RJ.
    Bioorg Med Chem; 2011 Aug 15; 19(16):4851-60. PubMed ID: 21767954
    [Abstract] [Full Text] [Related]

  • 26. Reductive activation of 5-fluorodeoxyuridine prodrug possessing azide methyl group by hypoxic X-irradiation.
    Tanabe K, Ishizaki J, Ando Y, Ito T, Nishimoto S.
    Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1682-5. PubMed ID: 22248856
    [Abstract] [Full Text] [Related]

  • 27. Nitro reduction as an electronic switch for bioreductive drug activation.
    Siim BG, Denny WA, Wilson WR.
    Oncol Res; 1997 Feb 15; 9(6-7):357-69. PubMed ID: 9406242
    [Abstract] [Full Text] [Related]

  • 28. Homogeneous solvation controlled photoreduction of cobalt(III) complexes in aqueous 2-methyl-2-propanol solutions linear solvation energy relationship and cyclic voltammetric analyses.
    Anbalagan K, Lydia IS.
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Mar 15; 69(3):964-70. PubMed ID: 17698408
    [Abstract] [Full Text] [Related]

  • 29. Towards bioreductively activated prodrugs: Fe(III) complexes of hydroxamic acids and the MMP inhibitor marimastat.
    Failes TW, Hambley TW.
    J Inorg Biochem; 2007 Mar 15; 101(3):396-403. PubMed ID: 17197030
    [Abstract] [Full Text] [Related]

  • 30. Chemical radiosensitizers for use in radiotherapy.
    Wardman P.
    Clin Oncol (R Coll Radiol); 2007 Aug 15; 19(6):397-417. PubMed ID: 17478086
    [Abstract] [Full Text] [Related]

  • 31. Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug.
    Hong CR, Mehta SY, Liyanage HDS, McManaway SP, Lee HH, Jaiswal JK, Bogle G, Tercel M, Pruijn FB, Wilson WR, Hicks KO.
    Cancer Chemother Pharmacol; 2021 Oct 15; 88(4):673-687. PubMed ID: 34245333
    [Abstract] [Full Text] [Related]

  • 32. Preparation and antitumour properties of the enantiomers of a hypoxia-selective nitro analogue of the duocarmycins.
    Tercel M, Lee HH, Yang S, Liyanage HD, Mehta SY, Boyd PD, Jaiswal JK, Tan KL, Pruijn FB.
    ChemMedChem; 2011 Oct 04; 6(10):1860-71. PubMed ID: 21793220
    [Abstract] [Full Text] [Related]

  • 33. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.
    Duan JX, Jiao H, Kaizerman J, Stanton T, Evans JW, Lan L, Lorente G, Banica M, Jung D, Wang J, Ma H, Li X, Yang Z, Hoffman RM, Ammons WS, Hart CP, Matteucci M.
    J Med Chem; 2008 Apr 24; 51(8):2412-20. PubMed ID: 18257544
    [Abstract] [Full Text] [Related]

  • 34. Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer.
    Lalani AS, Alters SE, Wong A, Albertella MR, Cleland JL, Henner WD.
    Clin Cancer Res; 2007 Apr 01; 13(7):2216-25. PubMed ID: 17404106
    [Abstract] [Full Text] [Related]

  • 35. Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.
    Mathuber M, Schueffl H, Dömötör O, Karnthaler C, Enyedy ÉA, Heffeter P, Keppler BK, Kowol CR.
    Inorg Chem; 2020 Dec 07; 59(23):17794-17810. PubMed ID: 33222438
    [Abstract] [Full Text] [Related]

  • 36. XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexes.
    Bonnitcha PD, Hall MD, Underwood CK, Foran GJ, Zhang M, Beale PJ, Hambley TW.
    J Inorg Biochem; 2006 May 07; 100(5-6):963-71. PubMed ID: 16624414
    [Abstract] [Full Text] [Related]

  • 37. Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.
    O'Neill ES, Kaur A, Bishop DP, Shishmarev D, Kuchel PW, Grieve SM, Figtree GA, Renfrew AK, Bonnitcha PD, New EJ.
    Inorg Chem; 2017 Aug 21; 56(16):9860-9868. PubMed ID: 28766939
    [Abstract] [Full Text] [Related]

  • 38. A novel class of antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiation.
    Shibamoto Y, Zhou L, Hatta H, Mori M, Nishimoto S.
    Jpn J Cancer Res; 2000 Apr 21; 91(4):433-8. PubMed ID: 10804292
    [Abstract] [Full Text] [Related]

  • 39. Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs.
    Thomson P, Naylor MA, Stratford MR, Lewis G, Hill S, Patel KB, Wardman P, Davis PD.
    Bioorg Med Chem Lett; 2007 Aug 01; 17(15):4320-2. PubMed ID: 17517505
    [Abstract] [Full Text] [Related]

  • 40. Co(III) complexes with N2(SO)2-type equatorial planar ligands similar to the active center of nitrile hydratase: role of the sulfenate group in the enzymatic reaction.
    Yano T, Wasada-Tsutsui Y, Arii H, Yamaguchi S, Funahashi Y, Ozawa T, Masuda H.
    Inorg Chem; 2007 Nov 26; 46(24):10345-53. PubMed ID: 17958357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.